Home / Inspections / 883362

FDA Inspection 883362 — Niagara Pharmaceuticals Inc

Niagara Pharmaceuticals Inc — FEI 3003093882

The FDA completed an inspection of Niagara Pharmaceuticals Inc on May 14, 2014 in Dundas. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 14, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dundas (Canada)

Facility

Other inspections at this facility

  • 1167881 (VAI Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117142 (OAI Fri Feb 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031416 (NAI Mon Sep 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 975165 (VAI Mon May 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694739 (VAI Wed Sep 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources